U.S. INFLUENZA VACCINES MARKET ANALYSIS
The U.S. influenza vaccines market is estimated to be valued at US$ 3,975.7 million in 2022 and is expected to exhibit a CAGR of 16.3% during the forecast period (2022-2030).
Figure 1. U.S. Influenza Vaccines Market Share (%), by Vaccine Type, 2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
